FUM.L
Futura Medical plc [FUM.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
FUM.L Stock Summary
Top 10 Correlated ETFs
FUM.L
Top 10 Correlated Stocks
FUM.L
In the News
FUM.L Financial details
Company Rating
-
Market Cap
109.12M
Income
-12.36M
Revenue
3.1M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
12
Optionable
No
Shortable
Yes
Earnings
03 Apr 2024
P/E
-21.09
Forward P/E
-
PEG
-1.95
P/S
-
P/B
26.13
P/C
-
P/FCF
-18.5
Quick Ratio
2.3
Current Ratio
3.03
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.04
EPS next Y
-
EPS next Q
-
EPS this Y
8.87%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-12.71%
Revenue last 5Y
149.96%
Revenue Q/Q
-17.96%
EPS Q/Q
159.02%
-
-
-
-
SMA20
-10.53%
SMA50
-35.17%
SMA100
-72.4%
Inst Own
-
Inst Trans
-
ROA
-90%
ROE
-81%
ROC
-1.46%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
23.282-67.0
52W High
-86.81%
52W Low
-61.57%
RSI
34.73
Rel Volume
0.96
Avg Volume
859.36K
Volume
825.77K
Perf Week
-0.45%
Perf Month
-22.79%
Perf Quarter
-76.98%
Perf Half Y
-77.13%
-
-
-
-
Beta
1.261
-
-
Volatility
0.18%, 0.51%
Prev Close
-4.54%
Price
8.84
Change
-11.42%
Company Profile
- Volume Average 859.36K
- Market Capitalization 109.12M
- Employee 12
- CEO Mr. James Henry Barder
- Headquarters Guildford,GB
- IPO Date 2003-07-22
-
Website
https://www.futuramedical.com 
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. The company was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
